- Company Directors - B
- Barrett Peter
Insider Trading History of Barrett Peter
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Barrett Peter since 2006.
The trader's CIK number is 1291895.
At the time of the last reporting, Barrett Peter was the Officer of Perkinelmer Inc. (stock ticker symbol PKI).
Also see all insider trading activities at Perkinelmer Inc.
Note that in the past
Barrett Peter also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Helicos Biosciences Corp (HLCS) by Barrett Peter
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2009 | HLCS | 242,931 | $0 | 0 | $0 | 0 | $0 |
2008 | HLCS | 8,620,690 | $0 | 0 | $0 | 0 | $0 |
2007 | HLCS | 333,333 | $2,999,997 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Vitae Pharmaceuticals, Inc (VTAE) by Barrett Peter
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2014 | VTAE | 37,500 | $300,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Perkinelmer Inc (PKI) by Barrett Peter
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | PKI | 0 | $0 | 7,552 | $756,038 | 4,750 | $199,903 |
2019 | PKI | 0 | $0 | 5,601 | $524,371 | 5,601 | $170,886 |
2017 | PKI | 0 | $0 | 17,071 | $1,134,794 | 17,071 | $457,917 |
Yearly summary of insider trading at Alnylam Pharmaceuticals, Inc. (ALNY) by Barrett Peter
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2006 | ALNY | 0 | $0 | 833,931 | $13,438,236 | 0 | $0 |
Insider trading activities at 4 companies by Barrett Peter:
1. Helicos Biosciences Corp (HLCS)
2. Vitae Pharmaceuticals, Inc (VTAE)
3. Perkinelmer Inc (PKI)
4. Alnylam Pharmaceuticals, Inc. (ALNY)
Table 1. Insider trading of Helicos Biosciences Corp (HLCS) by Barrett Peter
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2009-09-18 | HLCS | Buy | 242,931 | .00 | 0 |
2008-12-23 | HLCS | Buy | 8,620,690 | .00 | 0 |
2007-05-30 | HLCS | Buy | 333,333 | 9.00 | 2,999,997 |
Table 2. Insider trading of Vitae Pharmaceuticals, Inc (VTAE) by Barrett Peter
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2014-09-29 | VTAE | Buy | 37,500 | 8.00 | 300,000 |
Table 3. Insider trading of Perkinelmer Inc (PKI) by Barrett Peter
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-05-28 | PKI | Option Ex | 4,750 | 42.09 | 199,903 |
2020-05-28 | PKI | Sale | 7,552 | 100.11 | 756,038 |
2019-02-13 | PKI | Option Ex | 5,601 | 30.51 | 170,886 |
2019-02-13 | PKI | Sale | 5,601 | 93.62 | 524,371 |
2017-11-13 | PKI | Sale | 7,071 | 71.07 | 502,564 |
2017-11-13 | PKI | Option Ex | 7,071 | 27.79 | 196,467 |
2017-06-01 | PKI | Option Ex | 10,000 | 26.14 | 261,450 |
2017-06-01 | PKI | Sale | 10,000 | 63.22 | 632,230 |
Table 4. Insider trading of Alnylam Pharmaceuticals, Inc. (ALNY) by Barrett Peter
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2006-03-07 | ALNY | Sale | 21,800 | 16.50 | 359,809 |
2006-03-03 | ALNY | Sale | 178,782 | 16.89 | 3,018,912 |
2006-03-06 | ALNY | Sale | 63,200 | 17.20 | 1,086,913 |
2006-03-02 | ALNY | Sale | 61,900 | 16.06 | 994,361 |
2006-03-01 | ALNY | Sale | 75,200 | 16.06 | 1,207,411 |
2006-02-27 | ALNY | Sale | 250,000 | 15.77 | 3,942,750 |
2006-02-28 | ALNY | Sale | 91,549 | 15.98 | 1,463,319 |
2006-02-23 | ALNY | Sale | 31,500 | 15.14 | 476,941 |
2006-02-24 | ALNY | Sale | 60,000 | 14.80 | 887,820 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Barrett Peter
(Officer of Perkinelmer Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.